In vitro inferiority of ceftazidime compared with other β-lactams for viridans group streptococcus bacteremia in pediatric oncology patients: Implications for antibiotic choices

Journal of Pediatric Hematology/Oncology

Volumn 31, Issue 4, 2009, Pages 267-269

  Paulus, Stéphane ^a,b,e   Dobson, Simon ^a,b   Rassekh, Shahrad ^c   Blondel Hill, Edith ^d  

^a Division of Infectious Diseases   (Canada)

^b Department of Paediatrics ^*  (Canada)

^c Division of Oncology   (Canada)

^d BC CHILDREN S HOSPITAL   (Canada)

^e ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFTAZIDIME; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; DRUG DERIVATIVE; PENICILLANIC ACID; PENICILLIN DERIVATIVE; PIPERACILLIN; PIPERACILLIN TAZOBACTAM COMBINATION PRODUCT; PIPERACILLIN-TAZOBACTAM COMBINATION PRODUCT;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BLOOD CULTURE; CHILDHOOD CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG CHOICE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ACUTE GRANULOCYTIC LEUKEMIA; CHILD; DRUG COMBINATION; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; STREPTOCOCCUS INFECTION;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAM RESISTANCE; CEFOTAXIME; CEFTAZIDIME; CHILD; DRUG THERAPY, COMBINATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; MICROBIAL SENSITIVITY TESTS; PENICILLANIC ACID; PENICILLINS; PIPERACILLIN; RETROSPECTIVE STUDIES; STREPTOCOCCAL INFECTIONS; VIRIDANS STREPTOCOCCI;

EID: 65349192028     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31819a5d40     Document Type: Article

References (11)

1. Bruckner L, Gigliotti F. Viridans group streptococcal infections among children with cancer and the importance of emerging antibiotic resistance. Semin Pediatr Infect Dis. 2006; 17:153-160.
2. Okamoto Y, Ribeiro RC, Srivastava DK, et al. Viridans streptococcal sepsis: clinical features and complications in childhood acute myeloid leukemia. J Pediatr Hematol Oncol. 2003;25:696-703.
3. Danilatou V, Mantadakis E, Galanakis E, et al. Three cases of viridans group streptococcal bacteremia in children with febrile neutropenia and literature review. Scand J Infect Dis. 2003;35: 873-876.
4. Paganini H, Staffolani V, Zubizarreta P, et al. Viridans Streptococci bacteraemia in children with fever and neutrope-nia: a case-control study of predisposing factors. Eur J Cancer. 2003;39:1284-1289.
5. Ariffin H, Arasu A, Mahfuzah M, et al. Single-daily ceftriaxone plus amikacin versus thrice-daily ceftazidime plus amikacin as empirical treatment of febrile neutropenia in children with cancer. J Paediatr Child Health. 2001;37:38-43.
6. Granowetter L, Wells H, Lange BJ. Ceftazidime with or without vancomycin versus cephalothin, carbenicillin, and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient. Pediatr Infect Dis J. 1988;7:165-170.
7. Fleischhack G, Hartmann C, Simon A, et al. Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer. J Antimicrob Chemother. 2001;47:841-853.
8. Cometta A, Calandra T, Gaya H, et al. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program. Antimicrob Agents Chemother. 1996;40:1108-1115.
9. Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002;34:730-751.
10. Owens RC, Owens CA, Holloway WJ. Reduction in vanco-mycin consumption in patients with fever and neutropenia (abstract 458). Clin Infec Dis. 2000;31:291.
11. Kennedy HF, Gemmell CG, Bagg J, et al. Antimicrobial susceptibility of blood culture isolates of viridans streptococci: relationship to a change in empirical antibiotic therapy in febrile neutropenia. J Antimicrob Chemother. 2001;47:693-696.